Background/Objectives: Modern dentistry focuses on the ongoing development of digital alternative technologies and the study of the properties of these innovative materials is deemed essential. Therefore, the objectives of this study were to evaluate the optical and surface characteristics of six computer-aided design/Computer-Aided Manufacturing (CAD-CAM) dental materials, both subtractive and additive, in relation to in vitro degradation. Methods: CAD-CAM dental materials, subtractively processed (Vita Enamic, Cerasmart, Brilliant and Tetric) and additively manufactured (Saremco Crowntec and Voco C&B), were prepared to standard dimensions of 14 × 10 × 1 mm, with baseline measurements taken prior to, and after, the degradation procedures, consisting of immersion in an ADA-recommended staining broth, artificial aging (thermocycling), and the combined effects of staining and in vitro aging. Additionally, two different surface treatments were investigated (polished and glazed). Results: The poorest color stability was observed for Tetric glazed specimens (mean value 25.585) subjected to staining, while the best performance was recorded for Brilliant polished Control (average value of 0.781). The staining procedure produced the most pronounced color changes. Surface treatment did not significantly affect color stability, and surface roughness was not influenced by either the degradation method or the surface treatment (p > 0.05). Atomic Force Microscopy (AFM) evaluation revealed superior performance of the glazed surfaces, characterized by lower nanoroughness values compared with polished surfaces and a smoother surface appearance. Conclusions: The staining potential of staining broth was demonstrated in this study, with the highest values recorded after the staining procedures. In addition, the influence of artificial aging alone and artificial aging combined with staining was investigated, providing relevant results for a better clinical approach. Moreover, surface treatment demonstrated reliability and therefore clinical applicability.
Osiceanu et al. (Fri,) studied this question.